These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12618277)

  • 1. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes.
    Sampson MJ; Davies IR; Braschi S; Ivory K; Hughes DA
    Atherosclerosis; 2003 Mar; 167(1):129-34. PubMed ID: 12618277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36.
    Kapinsky M; Torzewski M; Büchler C; Duong CQ; Rothe G; Schmitz G
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1004-10. PubMed ID: 11397711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages.
    Devaraj S; Hugou I; Jialal I
    J Lipid Res; 2001 Apr; 42(4):521-7. PubMed ID: 11290823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages.
    Draude G; Lorenz RL
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1042-8. PubMed ID: 10749696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal fragment of alpha1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor.
    Janciauskiene S; Moraga F; Lindgren S
    Atherosclerosis; 2001 Sep; 158(1):41-51. PubMed ID: 11500173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset.
    Draude G; von Hundelshausen P; Frankenberger M; Ziegler-Heitbrock HW; Weber C
    Am J Physiol; 1999 Apr; 276(4):H1144-9. PubMed ID: 10199836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
    Iwashima Y; Eto M; Hata A; Kaku K; Horiuchi S; Ushikubi F; Sano H
    Biochem Biophys Res Commun; 2000 Oct; 277(2):368-80. PubMed ID: 11032732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma.
    Matsuura F; Yamashita S; Hirano K; Ishigami M; Hiraoka H; Tamura R; Nakagawa T; Nishida M; Sakai N; Nakamura T; Nozaki S; Funahashi T; Matsumoto C; Higashiyama M; Yoshikawa K; Matsuzawa Y
    Atherosclerosis; 1999 Feb; 142(2):355-65. PubMed ID: 10030387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scavenger receptors and oxidized low density lipoproteins.
    Dhaliwal BS; Steinbrecher UP
    Clin Chim Acta; 1999 Aug; 286(1-2):191-205. PubMed ID: 10511292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions.
    Hirano K; Yamashita S; Nakagawa Y; Ohya T; Matsuura F; Tsukamoto K; Okamoto Y; Matsuyama A; Matsumoto K; Miyagawa J; Matsuzawa Y
    Circ Res; 1999 Jul; 85(1):108-16. PubMed ID: 10400916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
    Guy RA; Maguire GF; Crandall I; Connelly PW; Kain KC
    Atherosclerosis; 2001 Mar; 155(1):19-28. PubMed ID: 11223422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis: cell biology and lipoproteins.
    Daugherty A
    Curr Opin Lipidol; 1998 Dec; 9(6):613-5. PubMed ID: 10075482
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis.
    Nicholson AC; Han J; Febbraio M; Silversterin RL; Hajjar DP
    Ann N Y Acad Sci; 2001 Dec; 947():224-8. PubMed ID: 11795270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36.
    Han J; Hajjar DP; Tauras JM; Nicholson AC
    J Lipid Res; 1999 May; 40(5):830-8. PubMed ID: 10224152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages.
    Tsukamoto K; Kinoshita M; Kojima K; Mikuni Y; Kudo M; Mori M; Fujita M; Horie E; Shimazu N; Teramoto T
    J Atheroscler Thromb; 2002; 9(1):57-64. PubMed ID: 12238639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages.
    Hrboticky N; Draude G; Hapfelmeier G; Lorenz R; Weber PC
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1267-75. PubMed ID: 10323779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells.
    Pietsch A; Erl W; Lorenz RL
    Biochem Pharmacol; 1996 Aug; 52(3):433-9. PubMed ID: 8687497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of CD36 and FcgammaRI.
    Carvalho MD; Vendrame CM; Ketelhuth DF; Yamashiro-Kanashiro EH; Goto H; Gidlund M
    J Atheroscler Thromb; 2010 Aug; 17(8):844-57. PubMed ID: 20467189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.
    Fuhrman B; Koren L; Volkova N; Keidar S; Hayek T; Aviram M
    Atherosclerosis; 2002 Sep; 164(1):179-85. PubMed ID: 12119208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.